A historical perspective on the specific activity of radiopharmaceuticals: What have we learned in the 35 years of the ISRC?

Nuclear Medicine and Biology

Volumn 39, Issue 5, 2012, Pages 601-608

  Lapi, Suzanne E ^a   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUOROETHANOL F 18; CARBON 11; CLOMIPRAMINE; FLUORINE 18; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; ISOTOPE ANALYSIS; ISOTOPE LABELING; ISOTOPE TRACING; MOLECULAR IMAGING; PROCESS DEVELOPMENT; RADIATION DOSE; RADIATION EXPOSURE; RADIOACTIVE CONTAMINATION; RADIOACTIVITY; RADIOASSAY; REVIEW; STRUCTURE ANALYSIS; THIN LAYER CHROMATOGRAPHY;

CONGRESSES AS TOPIC; CONTRAST MEDIA; DATABASES, FACTUAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MOLECULAR IMAGING; RADIOCHEMISTRY; RADIOPHARMACEUTICALS;

EID: 84862621158     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.11.005     Document Type: Review

References (38)

1. Fowler J.S., et al. Serotonin-C-11-tracer for pulmonary endothelial extraction of serotonin. J Labelled Comp Radiopharm 1977, 13(2):194-195.
2. Maziere M., Berger G., Comar D. Optimization of C-11 labeling of radiopharmaceuticals - C-11 clomipramine as an example. J Labelled Comp Radiopharm 1977, 13(2):196-197.
3. Reiffers S., et al. Synthesis of C-11 labeled Dopa/Dopa. J Labelled Comp Radiopharm 1977, 13(2):198-199.
4. Vaalburg W., et al. Preparation of C-11 labeled 17alpha-ethynylestradiol. J Labelled Comp Radiopharm 1977, 13(2):200-201.
5. Wieland B.W., et al. Development of cyclotron targetry and remote radiochemical techniques for continuous large-scale production of C-11-labeled amino-acids. J Labelled Comp Radiopharm 1977, 13(2):202.
6. Washburn L.C., et al. C-11-labeled amino-acids as agents for tumor and pancreas visualization. J Labelled Comp Radiopharm 1977, 13(2):203.
7. Casella V.R., Ido T., Wolf A.P. Production of anhydrous F-18 for nuclear-medicine. J Labelled Comp Radiopharm 1977, 13(2):209.
8. Lemire A., Schroader K.J., Reed M.F. Preparation of F-18-labeled tobacco-smoke. J Labelled Comp Radiopharm 1977, 13(2):211.
9. Dekleijn J.P., et al. Labeling with reactor produced F-18.3 polymer supported F-18 as a fluorinating agent. Int J Appl Radiat Isot 1977, 28(6):591-594.
10. Tewson T.J., Welch M.J. Preparation and preliminary biodistribution of no carrier added F-18 fluoroethanol. J Nucl Med 1980, 21(6):559-564.
11. Larsen P., et al. Synthesis of [C-11]iodomethane by iodination of [C-11]methane. Appl Radiat Isot 1997, 48(2):153-157.
12. 2. J Labelled Comp Radiopharm 1995, 37:76-78.
13. Sarkadi E., Elsinga P.H., Visser T.J., Luurtsema G., Vallburg W., Kovacs Z. 1997.
14. Holschbach M., Schirrmacher R., Solbach, Hamkens W., Coenen H.H. 1997.
15. Bonasera T.A., Lidstrom P., Lu L., Bergstrom, Langstrom B. 1997.
16. Oh S.J., Choe Y.S., Kim S.E., Choi Y., Lee K.H., Ha H.J., et al. 1997.
17. Bergman J., Lehikoinen P., Solin O. 1997.
18. Kessler L., Development of novel ligands for PET imaging of metabotropic glutamate receptor subtype 5. 2006, Switzerland.
19. Sasaki M., et al. An improved automated synthesis and in vivo evaluation of PET radioligand for serotonin re-uptake sites: [11C]McN5652X]. Kaku Igaku 1996, 33(12):1319-1327.
20. Noguchi J., Suzuki K. Automated synthesis of the ultra high specific activity of [C-11]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol 2003, 30(3):335-343.
21. Zhang M.R., et al. Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [(11)C]DAC with ultra-high specific activity. Neuroimage 2011, 54(1):123-130.
22. Zhang M.R., et al. Imaging of the translocator protein (18 kDa) in rat brain after ischemia using [(11)C]DAC with ultra-high specific activity. Synapse 2010, 64(6):488-493.
23. Andersson J., Truong P., Halldin C. An increased specific radioactivity of [(11)C]Hcn was obtained using in-target produced [(11)C]methane. J Labelled Comp Radiopharm 2005, 48:S108.
24. Turton D.R., Yau K. HPLC UV detector response to radioactivity in the analysis of PET radiotracers. J Labelled Comp Radiopharm 2005, 48:S139.
25. Tu Z., et al. A novel F-18 labeled sigma(2) receptor ligand for imaging breast cancer. J Labelled Comp Radiopharm 2005, 48:S280.
26. de Vries E.F.J., et al. The effect OF P-glycoprotein (Pgp) modulation on specific uptake of substituted [(18)F]MPPF derivatives. J Labelled Comp Radiopharm 2005, 48:S1.
27. Zeng F., et al. Synthesis and evaluation of (18)F-labeled FIMPYD as a PET imaging agent for beta-amyloid plaques. J Labelled Comp Radiopharm 2005, 48:S41.
28. Wuest F., et al. Synthesis and characterization of [(18)F]Mcl-322 as a potential PET radiotracer for imaging the dopamine transporter. J Labelled Comp Radiopharm 2005, 48:S204.
29. Saigal N., et al. Towards a metabolically stable fluorine-18 PET radiotracer for serotonin 5HT(1a) receptors. J Labelled Comp Radiopharm 2005, 48:S85.
30. Blagoev M., et al. Radiosynthesis and evaluation of (18)F-Agc393 as a biological marker of beta-amyloid deposits. J Labelled Comp Radiopharm 2005, 48:S319.
31. Horvath G.M., Popkov A., Elsinga P.H. Modifications in synthesis of [(18)F]-peptides and application to substance P. J Labelled Comp Radiopharm 2005, 48:S212.
32. Kim H.W., et al. Synthesis of [(18)F]fluoromethylspiperone ([(18)F]Fmsp) via [(18)F]fluoromethyl triflate synthesis. J Labelled Comp Radiopharm 2005, 48:S231.
33. Pichika R., et al. Nicotinic alpha 4 beta 2 receptor imaging agents - part II. Synthesis and biological evaluation of 2-[F-18]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (F-18-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 2006, 33(3):295-304.
34. Grunder G., et al. Quantification of D-2-like dopamine receptors in the human brain with F-18-desmethoxyfallypride. J Nucl Med 2003, 44(1):109-116.
35. Solin O., et al. Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([F-18]SPA-RQ). Molec Imaging Biol 2004, 6(6):373-384.
36. Chen X., et al. F-18-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 2004, 31(2):179-189.
37. Satyamurthy N., et al. Tantalum [18O]water target for the production of [18F]fluoride with high reactivity for the preparation of 2-deoxy-2-[18F]fluoro-d-glucose. Mol Imaging Biol 2002, 4(1):65-70.
38. Fuchtner F., et al. Factors affecting the specific activity of [18F]fluoride from a [18O]water target. Nuklearmedizin 2008, 47(3):116-119.